← boothcheck

ELV vs OSCR stock comparison

ELEVANCE HEALTH, INC. vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Elevance is what insurance at scale looks like: 47 million members' worth of premium flowing at a 2.6% net margin, an 11.9% return on equity, a dividend, and a 16.8 times multiple. Oscar is what insurance as software pitch looks like: a 15.2% operating margin that still nets negative, no multiple, and a 28.5% free-cash figure that is float rather than earnings. The scale gap is 9-to-1, $87B against $10B. Oscar's clean 0.26-turn balance sheet keeps the experiment funded; Elevance's 0.72 turns fund buybacks. The incumbent's price asks it to survive a bad rate cycle; the challenger's asks it to invent a profitable business model. Only one of those has been done before.

Comparison updated 2026-07-10.

ELV vs OSCR: the numbers

MetricELVOSCR
Price$395.20$29.79
Market cap$87.1B$9.8B
SectorManaged CareManaged Care
StageMatureGrowth
P/E16.8
P/B1.985.89
P/S0.430.74
EV/EBITDA17.9309.2
Revenue growth+9.5%+30.5%
Operating margin4.2%15.2%
Net margin2.6%-0.3%
Return on equity11.9%-2.4%
Return on assets4.2%-0.4%
Return on invested capital6.2%0.5%
FCF yield7.4%28.5%
Dividend yield1.5%
Debt / equity0.720.26
Current ratio1.481.09
Altman Z (solvency)2.892.14
Piotroski F (quality)7 / 98 / 9
Full ELV report → Full OSCR report →
Get boothcheck's read on ELV and OSCR, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.